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A B S T R A C T
Isolates of Pasteurella multocida recovered from infected humans (n= 15) were characterized by traditional and
molecular microbiological methods and were compared with cat-derived strains (n= 5). The most prevalent
subspecies among strains from human infections was P. multocida subsp. septica (80%), and nearly all isolates
showed a similar combination of virulence-associated genes. MLST analysis classiﬁed the 20 P. multocida strains
into 16 diﬀerent sequence types, and we assigned 11 new sequence types (ST), however, only one of those (ST
334) was shared by two human and one cat isolates. P. multocida subsp. septica strains formed a distinct phy-
logenetic group within the species. The strains showed resistance to erythromycin, clindamycin and sulfa-
methoxazole, and with two exceptions, resistance to tilmicosin was also detected. Each strain was susceptible to
ampicillin, streptomycin, gentamycin, tetracycline, doxycycline, cefazolin, cefpodoxime, chloramphenicol,
ﬂorfenicol and enroﬂoxacin. Common characteristics (virulence proﬁle and antibiotic sensitivity pattern) shared
by strains isolated from humans and cats support the view that domestic cats may serve as a potential reservoir
for P. multocida.
1. Introduction
Pasteurella multocida is a widespread veterinary pathogen and it also
has the potential to cause zoonotic infections in humans [1]. In animals,
P. multocida is associated with acute to chronic diseases such as fowl
cholera, atrophic rhinitis of swine, haemorrhagic septicaemia in buﬀalo
and cattle, and respiratory diseases in various host species [2–5]. Fur-
thermore, it is a natural inhabitant of the oropharyngeal ﬂora of dogs
and cats [6]. In humans, P. multocida infections have been reported
during the last few decades [7–9]. Humans acquire Pasteurella infection
primarily from injuries caused by companion animals, most typically
through animal bites, scratches, or licks on skin abrasions [7,8]. Bite
wound infection is the most common clinical manifestation that may
result in joint infections, abscess formation, cellulitis, lymphangitis,
meningitis, endocarditis, peritonitis, pneumonia or sepsis [10,11].
Systemic infections mainly aﬀect immunocompromised individuals
[12]. Although Pasteurella canis and Pasteurella dagmatis may also be
present in animal bites, P. multocida is the most prevalent species of the
Pasteurella genus causing human infections [13].
P. multocida strains can be classiﬁed into ﬁve capsular serogroups
(A, B, D, E and F) and 16 Heddleston serovars (1–16) based on their
capsular structure and lipopolysaccharide antigens [14–16]. Further-
more, 13 biovars can be diﬀerentiated according to their fermentation
of diﬀerent carbohydrates [17,18]. LPS structures of the 16 Heddleston
type strains were extensively studied by Harper et al. [19] who de-
scribed eight distinct LPS outer core biosynthesis loci (L1 – L8), and
developed a multiplex PCR scheme to diﬀerentiate these genotypes.
Several molecular typing methods have been used to reveal sus-
pected epidemiologic relationship between P. multocida infections in
humans and contact with animals.
In a number of studies, pulsed-ﬁeld gel electrophoresis (PFGE) has
been used to provide evidence for the zoonotic transmission of P.
multocida from animals to humans [10,20]. A multilocus sequence
typing (MLST) scheme has also been developed for studying the genetic
diversity of P. multocida [21] that has been used to characterize isolates
from various animal species [22,23].
The majority of the studies on P. multocida infections in humans
describe individual cases, and insuﬃcient information is usually
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accumulated on the strains isolated from such cases. To date, no study
has published an MLST investigation of human isolates of P. multocida,
and only limited data are available on the virulence gene proﬁle of P.
multocida isolated from humans [24]. Here we report the detailed in-
vestigation of 15 P. multocida clinical isolates obtained from human
infections in Hungary in comparison with ﬁve cat-derived strains of P.
multocida.
2. Material and methods
2.1. Bacterial isolates and identiﬁcation
The bacterial strains used in this study are described in Table 1.
Fifteen P. multocida strains of human origin were isolated from patients
at the Szent-Györgyi Albert Medical and Pharmaceutical Centre, Uni-
versity of Szeged, Hungary. Five strains of feline origin were used for
comparison. They were isolated from the oral cavities of cats and re-
presented various geographic locations without any connection to the
human cases. The isolates were cultured on Columbia agar (LAB M Ltd.,
Bury, UK) plates supplemented with 5% sheep blood under aerobic
conditions at 37 °C for 24 h. Their identity was conﬁrmed by a species-
speciﬁc PCR assay [25]. Combinations of oligonucleotide primers were
used for ampliﬁcation of kmt1 (species identiﬁcation), toxA (P. multo-
cida toxin), and hyaC-hyaD (capsular serogroup A) sequences in the
same reaction [26,27]. The other capsular types (B, D, E and F) were
identiﬁed using a multiplex PCR method as described previously [28].
The Heddleston serovar was determined using the gel diﬀusion pre-
cipitin test [15], and the result was conﬁrmed by the LPS multiplex PCR
[19]. Biovars were deﬁned via the carbohydrate fermentation patterns
and ornithine decarboxylase activity determined according to the
scheme developed by Fegan et al. [17] and Blackall et al. [18].
2.2. Molecular examinations
For DNA preparation, a loopful of cultured bacterial growth was
suspended in 50 μL sterile double-distilled water and heated in a
thermal cycler for 20min at 99 °C. Cellular debris were pelleted by
centrifugation and the supernatant was used as the DNA template for
PCR ampliﬁcation.
The main phylogenetic lineages of P. multocida were determined
using PCR-RFLP (PCR followed by a restriction fragment length poly-
morphism assay) based on 16S rDNA polymorphisms according to the
method of Sellyei et al. [29]. PCR products were digested using the
FastDigest™ HindIII restriction endonuclease as per the manufacturer’s
instructions (Thermo Scientiﬁc). Fragment lengths were determined
using agarose gel electrophoresis and images were recorded using
Kodak Molecular Imaging Software (version 5.0).
To determine the presence of virulence-associated genes, multiple
adhesins were tested including the type I and type IV ﬁmbrial subunits
(ﬁmA, ptfA), autotransporter adhesins (hsf-1, hsf-2), tight adherence
protein D (tadD) and ﬁlamentous haemagglutinin (pfhA). Genes were
detected by PCR as previously described [30,31]. The prevalence of
iron acquisition proteins (hgbA, hgbB, tbpA) and the neuraminidase gene
nanH was investigated according to the procedure of Ewers et al. [24]
and Atashpaz et al. [32]. All reactions were performed using a C1000
Thermal Cycler (Bio-Rad Laboratories, Inc., Berkeley, CA, USA).
MLST was performed as described by Subaaharan et al. [21]. Se-
quencing of PCR products was performed by Macrogen Europe (Am-
sterdam, The Netherlands). Nucleotide sequences were aligned and
compared using BioEdit software (version 7.2.3) [33]. Nucleotide se-
quence data were analysed using MEGA7 software [34]. The evolu-
tionary history was inferred using the neighbor-joining model with the
p-distance method, and the dataset was subjected to bootstrap analysis
of 1000 replicates. MLST alleles were assigned to the RIRDC MLST
database (https://pubmlst.org/pmultocida/). For making a comparison
on a wider range, a phylogenetic tree was constructed using all STs
available in the RIRDC MLST database. Then we cut the tree showing
only branches containing STs of our isolates together with previously
identiﬁed STs.
2.3. Antimicrobial resistance
Antimicrobial resistance was tested using minimal inhibitory con-
centration (MIC) test strips (Lioﬁlchem, Roseto, Italy). Susceptibility to
14 antimicrobial agents (ampicillin, cefazolin, cefpodoxime, strepto-
mycin, gentamycin, tetracycline, doxycycline, erythromycin, tilmi-
cosin, clindamycin, chloramphenicol, ﬂorfenicol, sulfamethoxazole and
enroﬂoxacin) was tested. Escherichia coli ATCC 25922 served as a
Table 1
Description and characteristics of P. multocida isolates obtained from humans and cats.
ID Specimen ST Capsular type Heddleston serovar LPS PCR hgbA hgbB nanH pfhA hsf1 tadD Subspeciesa Biovar Sorbitol fermentation
Human isolates
Pm242 abscess 330 A 1 L1 + + + – + – S 2 +
Pm243 wound 276 A 3 L3 + + + – – – S 2 +
Pm245 abscess 332 A 1 L1 + + + – – – S 7 –
Pm246 abscess 333 A 1 L1 + + + – – – S 7 –
Pm248 abscess 334 A 1 L1 + + + – – – S 7 –
Pm250 wound 335 F 1 L1 + + + – – – S 3 +
Pm251 wound 334 A 1 L1 + + + – – – S 7 –
Pm252 wound 336 A 3 L3 + + + – + – S 3 +
Pm254 surgery 337 A 1 L1 + + + – – – S 7 –
3080 wound 343 A 6 L4 + + + – – – S 10 –
3081 wound 333 A 1 L1 + + + – – – S 2 +
3083 wound 336 A 3 L3 + + + – – – S 3 +
Pm244 trachea 331 A 3 L3 + – + + + – M/G 6 –
Pm247 eye surgery 13 A 3 L3 + – + + – + M/G 9 +
Pm249 wound 71 A 3 L3 + + – – + – M/G 3 +
Cat isolates
3694 oral cavity 247 A 1 L1 + + + – – – S 2 +
3695 oral cavity 340 A 1 L1 + + + – – – S 2 +
3696 oral cavity 341 A 3 L3 + + + – – – M/G 3 +
3697 oral cavity 334 A 1 L1 + + + – – – S 7 –
3698 oral cavity 214 A 8 L7 – + + – – – M/G 12 +
Additional information: toxA, tbpA – all strains negative, ﬁmA, hsf2 – all strains positive, ptfA – all strains positive harbouring allelic variant B.
a S, subsp. septica; M/G, subsp. multocida/gallicida.
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quality control strain. The strains were cultured on Mueller–Hinton
agar plates supplemented with 5% sheep blood at 37 °C for 24 h.
Bacterial suspensions in phosphate-buﬀered saline, adjusted to a den-
sity of 0.5 McFarland, were spread onto Mueller–Hinton agar plates
supplemented with 5% sheep blood using a sterile swab. An MIC test
strip was placed on each plate after approximately 10min and the
plates were incubated at 37 °C for 24 h, following which the MIC values
were read according to the manufacturer’s instructions. We interpreted
the breakpoints according to Clinical and Laboratory Standards
Institute recommendations [35,36].
3. Results
The species-speciﬁc PCR conﬁrmed the identity of all isolates of P.
multocida used in this study (Table 1). The toxA gene was not detected
in any of the isolates. Type A was the most prevalent capsular type
detected among the human clinical isolates (14/15 strains), while the
capsule biosynthesis gene fcbD (serogroup F) was found in only one
case. All isolates from cats were of capsular type A. None of the isolates
harboured bcbD (serogroup B), dcbF (serogroup D) or ecbJ (serogroup E)
genes.
Among P. multocida human clinical isolates, Heddleston serovar 1
(53%) and 3 (40%) were the most frequently found serovars, while in
one case Heddleston serovar 6 was detected. Among the isolates from
cats, the Heddleston serovars detected were 1, 3 and 8. The result of the
gel diﬀusion precipitin test was fully conﬁrmed by the LPS multiplex
PCR.
The most prevalent subspecies among the strains isolated from
human infections was P. multocida subsp. septica (12/15 strains, 80%)
and the phylogenetic lineage speciﬁc for subsp. multocida/gallicida was
identiﬁed in three strains (20%). In P. multocida isolates from cats,
subsp. septica was detected in three cases and lineage-speciﬁc nucleo-
tide substitutions for subsp. multocida/gallicida were identiﬁed in two
strains.
Carbohydrate fermentation patterns and ornithine decarboxylase
activity recognized six diﬀerent biovars among the human clinical
isolates. Biovars 2, 3 and 7 were the most prevalent biovars; however,
biovars 6, 9 and 10 were also detected in individual cases. Isolates from
cats were assigned to biovars 2, 3, 7 or 12.
All P. multocida strains harboured type I and type IV ﬁmbrial sub-
units (ﬁmA, ptfA allelic variant B), the autotransporter adhesin (hsf-2)
and, in the majority of the strains, hgbA (95%) and hgbB (90%) were
also detected (Fig. 1), coding for haemoglobin binding proteins and the
neuraminidase coding gene nanH (95%). The transferrin binding pro-
tein encoded by the tbpA gene could not be detected in the strains
tested. In addition, some adhesion-related genes were identiﬁed in low
Fig. 1. Detection of virulence associated genes
of P. multocida by PCR in agarose gel.
Electrophoresis was performed in 1.5% agarose
gel (TopVision Agarose, Lonza Group Ltd.,
Basel, Switzerland) and a 100–3000 bp DNA
ladder (GeneRuler 1 kb Plus, Thermo Scientiﬁc
Inc.) was used as molecular weight marker (M).
PCR 1. Detection of hsf1 (654 bp), hsf2 (433
bp) and pfhA (286 bp) in a multiplex reaction.
PCR 2. Detection of ﬁmA (866 bp) and tadD
(416 bp).
PCR 3. Detection of hgbA (402 bp) and nanH
(340 bp).
PCR 4. Detection of hgbB (499 bp) and tbpA
(728 bp).
PCR 5. ptfA allele speciﬁc PCR.
Lane 1: negative control, Lane 2: Pm242, Lane
3: Pm243, Lane 4: Pm244, Lane 5: Pm247,
Lane 6: Pm249, Lane 7: positive control for
both hgbB and tbpA, Lane A: positive control for
ptfA allelic variant A (126 bp), Lane B: positive
control for ptfA allelic variant B (217 bp)
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prevalence, such as those encoding the autotransporter adhesin (hsf-1,
20%), ﬁlamentous haemagglutinin (pfhA, 10%) and tight adherence
protein D (tadD, 5%).
MLST analysis classiﬁed the 20 P. multocida strains into 16 diﬀerent
sequence types (STs). Interestingly, in most cases (11 of the 16 STs) the
allelic proﬁle could not be matched with the known STs deﬁned in the
MLST database. We therefore assigned 11 new STs.
Only three STs were represented by more than one strain: ST333
(n=2), ST334 (n= 3) and ST336 (n= 2). The P. multocida subsp.
septica strains were shown to be closely related phylogenetically
(Fig. 2). Comparison with the isolates in the RIRDC MLST database
indicated that P. multocida subsp. septica strains formed a distinct
phylogenetic group with high bootstrap support values within the
species P. multocida regardless of the host species. A neighbour-joining
dendrogram was constructed to display the genetic distance of these STs
(Fig. 3).
Based on MIC values (Table 2), the strains showed resistance to
erythromycin, clindamycin and sulfamethoxazole, and with two ex-
ceptions, resistance to tilmicosin was also detected. Each strain was
susceptible to ampicillin and other commonly used antimicrobials in-
cluding streptomycin, gentamycin, tetracycline, doxycycline, cefazolin,
cefpodoxime, chloramphenicol, ﬂorfenicol and enroﬂoxacin.
4. Discussion
P. multocida strains isolated from humans and cats were serotyped
and characterized according to their subspecies, capsular poly-
saccharide and virulence-associated genes. Their clonal relatedness was
also investigated by MLST.
In accordance with the data in the literature, type A proved to be the
most prevalent capsular serogroup among P. multocida strains from cats
and humans, and to the best of our knowledge, this is the ﬁrst detection
of capsular type F in a human case [5,24]. The dominant serovars
among human and feline P. multocida isolates were A:1 and A:3, which
widely occur in all of this bacteria’s host species [5]. Interestingly, in
two cases we identiﬁed the rarely reported Heddleston serovars 6 and 8,
respectively.
Subspecies diﬀerentiation is considered an important epidemiolo-
gical marker of P. multocida. In nearly all hosts, subsp. multocida is the
most frequently detected subspecies [17,18,37]. As an exception,
strains from cats and dogs usually belong to subsp. septica [38]. In this
study, subsp. septica was also identiﬁed as the predominant subspecies
in the human clinical isolates.
In an earlier study, Holst et al. [13] identiﬁed P. multocida subsp.
multocida as the most commonly recovered subspecies from infected
humans. However, they used traditional biochemical tests for the dif-
ferentiation of P. multocida subspecies, which have some inconsistencies
due to the range of sorbitol and dulcitol fermentation properties
amongst these strains [39]. In our work, we determined the main
phylogenetic lineages of P. multocida by PCR-RFLP based on 16S rDNA
polymorphisms. Biochemical proﬁle-based subspecies diﬀerentiation is
not always accurate [30,38,40], and we also found sorbitol positive
subsp. septica strains among our isolates (biovars 2 and 3). If only fer-
mentation properties had been taken into account, these strains would
have been misidentiﬁed as P. multocida subsp. multocida (Table 1.). In a
previous study, Chen et al. [41] noticed that the majority of the strains
recovered from respiratory infections in humans were P. multocida
subsp. multocida, while P. multocida subsp. septica strains dominated
isolates from wound infections. Donnio et al. [42] examining a larger
number of strains of P. multocida recovered from human patients found
that P. multocida subsp. multocida was the most common subspecies
(87.5%) equally occurring in both wound infections and respiratory
Fig. 2. Evolutionary relationships between P. multocida isolates obtained from cats and humans. The evolutionary history was inferred using the neighbour-joining
method. Evolutionary analyses were conducted using MEGA7 software [35].
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tract infections. In contrast, nearly all P. multocida subsp. septica strains
were isolated from bite wounds and rarely in respiratory or systemic
infections [42]. The majority of our isolates represented P. multocida
subsp. septica, and were recovered from infected wounds, while the only
isolate from the respiratory tract belonged to P. multocida subsp.
multocida. These ﬁndings provide further evidence that P. multocida
subsp. septica is more commonly found in soft tissues than to other sites
of the body.
With only two exceptions (Pm242 and Pm252), all P. multocida
subsp. septica isolates exhibited the same virulence gene proﬁle. These
Fig. 3. Evolutionary relationships among P. multocida strains from various hosts and disease phenotypes. The evolutionary history was inferred using the neighbour-
joining method. Evolutionary analyses were conducted using MEGA7 software [35].
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strains harboured genes encoding ptfA (allelic variant B), ﬁmA, hsf-2,
nanH, hgbA and hgbB, while genes encoding tbpA, pfhA, hsf-1 and tadD
were not detected. By contrast, strains belonging to the subsp. multo-
cida/gallicida lineage showed greater diversity among virulence genes.
Based on the seven genes in common across the two studies, Ewers et al.
[24] described a similar virulence gene pattern to that we found to be
characteristic of P. multocida subsp. septica strains; however, they did
not determine the subspecies and included only two strains of human
origin in their study. Recent research demonstrated the existence of two
independent iron acquisition strategies in P. multocida, with the hae-
moglobin and transferrin binding protein coding genes harboured by P.
multocida often being associated with certain host species [24]. Trans-
ferrin binding proteins appear to be speciﬁc to isolates from ruminants
[43]. Haemoglobin binding proteins A and B facilitate the increased
proliferation of the bacterium by acquiring hemin from the host, and
they are prevalent among P. multocida isolates from diﬀerent host
species. Our data conﬁrmed the ﬁndings by Ewers et al. [24] that the
hgbA and hgbB occur widely among isolates from humans and cats.
Our MLST results conﬁrmed the previous ﬁnding [44] that P. mul-
tocida subsp. septica and subsp. multocida strains were forming two
distinct clusters, with a number of newly described STs, and consider-
able diversity within each cluster. On the other hand, although there
are many human and feline isolates in both clusters, there are a number
of avian isolates and single porcine and bovine isolates as well. More-
over, for a number of the strains (e.g. 3080, 3083, Pm242, Pm 243,
Pm246, Pm252, Pm254) the closest relative strains as determined by
MLST are bovine/porcine or avian not feline. Based on the results of the
present study, P. multocida isolates from humans and cats have shown
little evidence of shared genotypes. The review of the RIRDC MLST
database of P. multocida strains from diﬀerent hosts suggests that si-
milar strains are circulating across host species [45,46].
The antimicrobial susceptibility of P. multocida strains from humans
has been evaluated in several studies, and the resistance patterns re-
main largely unchanged over time. Penicillin, later generation cepha-
losporins, tetracyclines, chloramphenicol and ﬂuoroquinolones seem to
be generally eﬀective against P. multocida isolates from humans,
whereas such strains are typically resistant to clindamycin and sul-
phonamides [7,9,47,48]. Recently, resistance to macrolides has
emerged in P. multocida [49]. Our results are in accordance with these
previous observations, and the susceptibility proﬁles of P. multocida
strains from humans and cats were found to be highly similar. Tradi-
tionally, penicillin or ampicillin were the antibiotics primarily re-
commended to treat P. multocida infection in humans [7,9], although
the emergence of β-lactamase-producing strains has also been described
[50]. All strains in this study, including the cat-derived isolates, have
been proven to be susceptible to ampicillin. To date, no resistance to
tetracycline and doxycycline has been reported in clinical isolates of P.
multocida from humans or pet animals, and all of our strains were
susceptible to both antibiotics. By contrast, resistance to tetracyclines
has been described in strains from pigs and ruminants [51,52]. Fur-
thermore, high rates of resistance to streptomycin, sulphonamide and
chloramphenicol have been reported in P. multocida isolates of porcine
and bovine origin [53–55]. These ﬁndings warn us that resistance may
emerge in isolates from other host species including human beings as
well. Similar to previous ﬁndings [54,55], strains susceptible to sul-
phonamides were not identiﬁed in the present study.
In summary, our results show that ampicillin, aminoglycosides,
tetracyclines, later generation cephalosporins, phenicols and enro-
ﬂoxacin may be still eﬀective against P. multocida infections in humans.
However, the application of macrolides, lincosamides and sulfa-
methoxazole should be avoided in the treatment of such infections.
In conclusion, some of the common characteristics (like virulence
proﬁle and antibiotic sensitivity pattern) shared by P. multocida strains
isolated from humans and cats support the view that domestic cats
serve as a major reservoir for P. multocida. This is partially contradicted
by the MLST results, however, the opportunity for regular contacts with
domestic animals further strengthen this presumption. The relatively
frequent isolation of P. multocida from human cases underlines the
zoonotic importance of this pathogen, and encourages its further ex-
amination from this aspect with special regard to the possible sources of
infection.
Conﬂict of Interest Statement
We declare that the authors have no conﬂict of interests.
Acknowledgements
We thank Kate Fox, DPhil, from Edanz Group (www.edanzediting.
com/ac) for editing a draft of this manuscript. This study was supported
by the National Research, Development and Innovation Oﬃce – Grant
NKFIH K124457. This publication made use of the Pasteurella multocida
MLST website (https://pubmlst.org/pmultocida/) sited at the
University of Oxford (Jolley & Maiden 2010, BMC Bioinformatics,
11:595). The development of this site has been funded by the Wellcome
Trust.
References
[1] T. Magyar, A.J. Lax, Bacteria: Pasteurella multocida, in: K.A. Brogden,
J.M. Guthmiller (Eds.), Encyclopedia of Food Safety, Academic Press, Waltham,
MA, 2014, pp. 476–479.
[2] K.R. Rhoades, R.B. Rimler, Fowl cholera, in: C.F. Adlam, J.M. Rutter (Eds.),
Pasteurella and Pasteurellosis, Academic Press, London, London, 1989, pp. 95–113.
[3] T. Magyar, A.J. Lax, Atrophic rhinitis, in: K.A. Brogden, J.M. Guthmiller (Eds.),
Polymicrobial Diseases, ASM Press, Washington DC, 2002, pp. 169–197.
[4] M.C.L. De Alwis, Haemorrhagic septicaemia - a general review, Br. Vet. J. 148
(1992) 99–112.
[5] J.D. Boyce, M. Harper, I.W. Wilkie, B. Adler, Pasteurella, in: C.L. Gyles,
J.F. Prescott, J.G. Songer, C.O. Thoen (Eds.), Pathogenesis of Bacterial Infections of
Animals, 4th ed, Blackwell Publishing, Ames, IA, 2010, pp. 325–346.
[6] R.D. Griego, T. Rosen, I.F. Orengo, J.E. Wolf, Dog, cat, and human bites: a review, J.
Am. Acad. Dermatol. 33 (1995) 1019–1029.
[7] D.J. Weber, J.S. Wolfson, M.N. Swartz, D.C. Hooper, Pasteurella multocida infec-
tions. Report of 34 cases and review of the literature, Medicine 63 (1984) 133–154.
[8] R. Kimura, Y. Hayashi, T. Takeuchi, M. Shimizu, M. Iwata, J. Tanahashi, M. Ito,
Pasteurella multocida septicemia caused by close contact with a domestic cat: case
report and literature review, J. Infect. Chemother. 10 (2004) 250–252.
[9] B.A. Wilson, M. Ho, Pasteurella multocida: from zoonosis to cellular microbiology,
Clin. Microbiol. Rev. 26 (2013) 631–655.
[10] W. Liu, R.F. Chemaly, M.J. Tuohy, M.M. LaSalvia, G.W. Procop, Pasteurella multo-
cida urinary tract infection with molecular evidence of zoonotic transmission, Clin.
Inf. Dis. 36 (2003) 58–60.
[11] F.M. Abrahamian, E.J. Goldstein, Microbiology of animal bite wound infections,
Clin. Microbiol. Rev. 24 (2011) 231–246.
[12] I.W. Wilkie, M. Harper, J.D. Boyce, B. Adler, Pasteurella multocida: diseases and
pathogenesis, in: K. Aktories, J.H.C. Orth, B. Adler (Eds.), Pasteurella multocida,
Springer, Berlin, Heidelberg, 2012, pp. 1–22.
[13] E. Holst, J. Rollof, L. Larsson, J.P. Nielsen, Characterization and distribution of
Pasteurella species recovered from infected humans, J. Clin. Microbiol. 30 (1992)
Table 2
Susceptibility rates of P. multocida isolates form human and cat origin. All va-
lues are expressed as μg/ml.
Antibiotics Human isolates Cat isolates
MIC50 MIC90 Susc. %a MIC50 MIC90 Susc. %a
Ampicillin 0.5 0.5 100 0.38 0.5 100
Cefazolin 0.75 0.5 100 0.75 1 100
Cefpodoxime 0.064 0.5 100 0.064 0.5 100
Streptomycin 32 32 100 32 32 100
Gentamycin 4 4 100 4 4 100
Tetracycline 0.19 0.25 100 0.125 0.19 100
Doxycycline 0.25 0.38 100 0.19 0.38 100
Erythromycin 12 32 0 12 16 0
Tilmicosin 32 32 13 32 32 0
Clindamycin 256 256 0 48 128 0
Chloramphenicol 1.5 4 100 3 3 100
Florfenicol 0.75 1 100 0.75 1 100
Sulfamethoxazole 256 256 0 256 256 0
Enroﬂoxacin 0.047 0.094 100 0.064 0.125 100
a Percentages of susceptible strains.
B. Ujvári et al. Comparative Immunology, Microbiology and Infectious Diseases 63 (2019) 37–43
42
Downloaded for Anonymous User (n/a) at HUNGARY - Szeged University from ClinicalKey.com by Elsevier on January 16, 2019.
For personal use only. No other uses without permission. Copyright ©2019. Elsevier Inc. All rights reserved.
2984–2987.
[14] G.R. Carter, Studies on Pasteurella multocida. I. A hemagglutination test for the
identiﬁcation of serological types, A. J. Vet. Res. 16 (1955) 481–484.
[15] K.L. Heddleston, J.E. Gallagher, P.A. Rebers, Fowl cholera: gel diﬀusion precipitin
test for serotyping Pasteurella multocida from avian species, Avian Dis. 16 (1972)
925–936.
[16] R.B. Rimler, K.R. Rhoades, Serogroup F, a new capsule serogroup of Pasteurella
multocida, J. Clin. Microbiol. 25 (1987) 615–618.
[17] N. Fegan, P.J. Blackall, J.L. Pahoﬀ, Phenotypic characterisation of Pasteurella mul-
tocida isolates from Australian poultry, Vet. Microbiol. 47 (1995) 281–286.
[18] P.J. Blackall, J.L. Pahoﬀ, R. Bowles, Phenotypic characterisation of Pasteurella
multocida isolates from Australian pigs, Vet. Microbiol. 57 (1997) 355–360.
[19] M. Harper, M. John, C. Turny, M. Edmunds, G. St. Michael, B. Adler, P.J. Blackall,
A.D. Cox, J.D. Boyce, Development of a rapid multiplex PCR assay to genotype
Pasteurella multocida strains by use of the lipopolysaccharide outer core biosynthesis
locus, J. Clin. Microbiol. 53 (2015) 477–485.
[20] A. Satomura, M. Yanai, T. Fujita, Y. Arashima, K. Kumasaka, C. Nakane, K. Ito,
Y. Fuke, T. Maruyama, N. Maruyama, K. Okada, T. Nakayama, K. Matsumoto,
Peritonitis associated with Pasteurella multocida: molecular evidence of zoonotic
etiology, Ther. Apher. Dial. 14 (2010) 373–376.
[21] S. Subaaharan, L.L. Blackall, P.J. Blackall, Development of a multi-locus sequence
typing scheme for avian isolates of Pasteurella multocida, Vet. Microbiol. 141 (2010)
354–361.
[22] E.J. Hotchkiss, J.C. Hodgson, F.A. Lainson, R.N. Zadoks, Multilocus sequence typing
of a global collection of Pasteurella multocida isolates from cattle and other host
species demonstrates niche association, BMC Microbiol. 11 (2011) 115.
[23] A. García-Alvarez, A.I. Vela, E. San Martín, F. Chaves, J.F. Fernández-Garayzábal,
D. Lucas, D. Cid, Characterization of Pasteurella multocida associated with ovine
pneumonia using multi-locus sequence typing (MLST) and virulence-associated
gene proﬁle analysis and comparison with porcine isolates, Vet. Microbiol. 204
(2017) 180–187.
[24] C. Ewers, A. Lübke-Becker, A. Bethe, S. Kießling, M. Filter, L.H. Wieler, Virulence
genotype of Pasteurella multocida strains isolated from diﬀerent hosts with various
disease status, Vet. Microbiol. 114 (2006) 304–317.
[25] K.M. Townsend, A.J. Frost, C.W. Lee, J.M. Papadimitriou, H.J. Dawkins,
Development of PCR assays for species-and type-speciﬁc identiﬁcation of Pasteurella
multocida isolates, J. Clin. Microbiol. 36 (1998) 1096–1100.
[26] R. Gautam, A.A. Kumar, V.P. Singh, V.P. Singh, T.K. Dutta, S.B. Shivachandra,
Speciﬁc identiﬁcation of Pasteurella multocida serogroup-A isolates by PCR assay,
Res. Vet. Sci. 76 (2004) 179–185.
[27] K.B. Register, K.D. DeJong, Analytical veriﬁcation of a multiplex PCR for identiﬁ-
cation of Bordetella bronchiseptica and Pasteurella multocida from swine, Vet.
Microbiol. 117 (2006) 201–210.
[28] K.M. Townsend, J.D. Boyce, J.Y. Chung, A.J. Frost, B. Adler, Genetic organization of
Pasteurella multocida cap loci and development of a multiplex capsular PCR typing
system, J. Clin. Microbiol. 39 (2001) 924–929.
[29] B. Sellyei, E. Wehmann, T. Magyar, Sequencing-independent method for the dif-
ferentiation of the main phylogenetic lineages of Pasteurella multocida, J. Vet. Diagn.
Invest. 24 (2012) 735–738.
[30] B. Sellyei, K. Bányai, T. Magyar, Characterization of the ptfA gene of avian
Pasteurella multocida strains by allele-speciﬁc polymerase chain reaction, J. Vet.
Diagn. Invest. 22 (2010) 607–610.
[31] X. Tang, Z. Zhao, J. Hu, B. Wu, X. Cai, Q. He, H. Chen, Isolation, antimicrobial
resistance, and virulence genes of Pasteurella multocida strains from swine in China,
J. Clin. Microbiol. 47 (2009) 951–958.
[32] S. Atashpaz, J. Shayegh, M.S. Hejazi, Rapid virulence typing of Pasteurella multocida
by multiplex PCR, Res. Vet. Sci. 87 (2009) 355–357.
[33] T. Hall, BioEdit: an important software for molecular biology, GERF Bull. Biosci. 2
(2011) 60–61.
[34] S. Kumar, G. Stecher, K. Tamura, MEGA7: molecular evolutionary genetics analysis
version 7.0 for bigger datasets, Mol. Biol. Evol. 33 (2016) 1870–1874.
[35] CLSI, Performance Standards for Antimicrobial Susceptibility Testing, 28th ed.,
CLSI supplement M100, Wayne, PA, USA, 2018.
[36] CLSI, Performance Standards for Antimicrobial Disk and Dilution Susceptibility
Tests for Bacteria Isolated From Animals, 3rd ed., CLSI supplement VET01S, Wayne,
PA, USA, 2018.
[37] S.O. Ekundayo, M.O. Odugbo, A.O. Olabode, P.A. Okewole, Phenotypic variability
among strains of Pasteurella multocida isolated from avian, bovine, caprine, leporine
and ovine origin, Afr. J. Biotechnol. 7 (2008) 1347–1350.
[38] P. Kuhnert, P. Boerlin, S. Emler, M. Krawinkler, J. Frey, Phylogenetic analysis of
Pasteurella multocida subspecies and molecular identiﬁcation of feline P. multocida
subsp. septica by 16S rRNA gene sequencing, Int. J. Med. Microbiol. 290 (2000)
599–604.
[39] P. Boerlin, H.H. Siegrist, A.P. Burnens, P. Kuhnert, P. Mendez, G. Prétat,
R. Lienhard, J. Nicolet, Molecular identiﬁcation and epidemiological tracing of
Pasteurella multocida meningitis in a baby, J. Clin. Microbiol. 38 (2000) 1235–1237.
[40] R.L. Davies, Genetic diversity among Pasteurella multocida strains of avian, bovine,
ovine and porcine origin from England and Wales by comparative sequence analysis
of the 16S rRNA gene, Microbiology 150 (2004) 4199–4210.
[41] H.I. Chen, K. Hulten, J.E. Clarridge, Taxonomic subgroups of Pasteurella multocida
correlate with clinical presentation, J. Clin. Microbiol. 40 (2002) 3438–3441.
[42] P.Y. Donnio, A.L. Lerestif-Gautier, J.L. Avril, Characterization of Pasteurella spp.
strains isolated from human infections, J. Comp. Pathol. 130 (2004) 137–142.
[43] S. Verma, M. Sharma, S. Katoch, L. Verma, S. Kumar, V. Dogra, R. Chahota, P. Dhar,
G. Singh, Proﬁling of virulence associated genes of Pasteurella multocida isolated
from cattle, Vet. Res. Commun. 37 (2013) 83–89.
[44] P.J. Blackall, N. Fegan, G.T. Chew, D.J. Hampson, Population structure and di-
versity of avian isolates of Pasteurella multocida from Australia, Microbiology 144
(1998) 279–289.
[45] R. Singh, B. Remington, P.J. Blackall, C. Turni, Epidemiology of fowl cholera in free
range broilers, Avian Dis. 58 (2014) 124–128.
[46] C. Turni, R. Singh, P.J. Blackall, Genotypic diversity of Pasteurella multocida isolates
from pigs and poultry in Australia, Aust. Vet. J. 96 (2018) 390–394.
[47] D.L. Stevens, J.W. Higbee, T.R. Oberhofer, E.D. Everett, Antibiotic susceptibilities of
human isolates of Pasteurella multocida, Antimicrob. Agents Chemother. 16 (1979)
322–324.
[48] E.S. Christenson, H.M. Ahmed, C.M. Durand, Pasteurella multocida infection in solid
organ transplantation, Lancet Inf. Dis. 15 (2015) 235–240.
[49] A. Freshwater, Why your housecat’s trite little bite could cause you quite a fright: a
study of domestic felines on the occurrence and antibiotic susceptibility of
Pasteurella multocida, Zoonoses Public Health 55 (2008) 507–513.
[50] E. Migliore, C. Serraino, C. Brignone, D. Ferrigno, A. Cardellicchio, F. Pomero,
E. Castagna, M. Osenda, L. Fenoglio, Pasteurella multocida infection in a cirrhotic
patient: case report, microbiological aspects and a review of literature, Adv. Med.
Sci. 54 (2009) 109.
[51] K. Katsuda, K. Hoshinoo, Y. Ueno, M. Kohmoto, O. Mikami, Virulence genes and
antimicrobial susceptibility in Pasteurella multocida isolates from calves, Vet.
Microbiol. 167 (2013) 737–741.
[52] D.A.E. Dayao, J.S. Gibson, P.J. Blackall, C. Turni, Antimicrobial resistance in bac-
teria associated with porcine respiratory disease in Australia, Vet. Microbiol. 171
(2014) 232–235.
[53] C. Kehrenberg, S. Schwarz, Occurrence and linkage of genes coding for resistance to
sulfonamides, streptomycin and chloramphenicol in bacteria of the genera
Pasteurella and Mannheimia, FEMS Microbiol. Lett. 205 (2001) 283–290.
[54] A. San Millan, J.A. Escudero, B. Gutierrez, L. Hidalgo, N. Garcia, M. Llagostera,
L. Dominguez, B. Gonzalez-Zorn, Multiresistance in Pasteurella multocida is medi-
ated by coexistence of small plasmids, Antimicrob. Agents Chemother. 53 (2009)
3399–3404.
[55] S.K. Glass-Kaastra, D.L. Pearl, R. Reid-Smith, B. McEwen, D. Slavic, J. Fairles,
S.A. McEwen, Multiple-class antimicrobial resistance surveillance in swine
Escherichia coli F4, Pasteurella multocida and Streptococcus suis isolates from Ontario
and the impact of the 2004–2006 Porcine Circovirus type-2 Associated Disease
outbreak, Prev. Vet. Med. 113 (2014) 159–164.
B. Ujvári et al. Comparative Immunology, Microbiology and Infectious Diseases 63 (2019) 37–43
43
Downloaded for Anonymous User (n/a) at HUNGARY - Szeged University from ClinicalKey.com by Elsevier on January 16, 2019.
For personal use only. No other uses without permission. Copyright ©2019. Elsevier Inc. All rights reserved.
